Cargando…

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?

Detalles Bibliográficos
Autores principales:	Vanhorebeek, I, Ellger, B, De Vos, R, Debaveye, Y, Vander Perre, S, Van den Berghe, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092616/ http://dx.doi.org/10.1186/cc4588

Ejemplares similares

Mechanisms of kidney protection by intensive insulin therapy during critical illness
por: Vanhorebeek, I, et al.
Publicado: (2008)

Organ dysfunction in critical illness: impact of maintaining normoglycemia and glycemia-independent insulin actions
por: Ellger, B, et al.
Publicado: (2006)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Intensive insulin therapy in critically ill children: impact on blood glucose dynamics and its relation with mortality
por: Van Tornout, M, et al.
Publicado: (2013)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Regulation of type 1 deiodinase activity in prolonged critical illness
por: Debaveye, Y, et al.
Publicado: (2006)

Intensive insulin therapy and brief hypoglycemia do not increase neurological injury markers in critically ill children
por: Gielen, M, et al.
Publicado: (2010)

Effects of hyperglycemia and intensive insulin therapy on neurons and glial cells during critical illness
por: Sonneville, R, et al.
Publicado: (2011)

Effect of intensive insulin therapy on coagulation and fibrinolysis of respiratory critically ill patients
por: Langouche, L, et al.
Publicado: (2007)

Alterations in adipose tissue during critical illness: an adaptive and protective response?
por: Langouche, L, et al.
Publicado: (2010)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Impact of early versus late parenteral nutrition on morphological and molecular markers of atrophy and autophagy in skeletal muscle of critically ill patients
por: Vanhorebeek, I, et al.
Publicado: (2013)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Blood glucose amplitude variation: effects of intensive insulin therapy and relative association with mortality
por: Bekaert, E, et al.
Publicado: (2010)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

Reduced cortisol metabolism drives hypercortisolism in critical illness
por: Boonen, E, et al.
Publicado: (2012)

Results of an intensive insulin infusion protocol in diabetic and nondiabetic critically ill patients
por: Gomes, PN, et al.
Publicado: (2005)

Neurocognitive consequences of iatrogenicphthalate exposure during critical illness in children: a study of a development and validation cohort
por: Verstraete, S, et al.
Publicado: (2015)

Insufficient autophagy relates to mitochondrial dysfunction, organ failure and adverse outcome in an animal model of critical illness
por: Gunst, J, et al.
Publicado: (2012)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

Endogenous insulin secretion in critically ill patients
por: Pretty, C, et al.
Publicado: (2012)

Time-course evaluation of blood glucose changes in response to insulin delivery in critically ill patients
por: Bass, F, et al.
Publicado: (2014)

Severe hypoglycaemia during intensive insulin therapy: a rare event in critically ill patients
por: Kaukonen, M, et al.
Publicado: (2007)

Errors in preparation of insulin infusions for critically ill patients
por: Pierson, R, et al.
Publicado: (2011)

Cytokines associated with insulin resistance in critically ill patients
por: Omar, S, et al.
Publicado: (2007)

Intensive insulin therapy versus glycemic control in critically ill patients: a prospective controlled trial
por: Azevedo, JR, et al.
Publicado: (2007)

Effect of glucose–insulin–potassium infusion on mortality in critically ill patients: a systematic review and meta-analysis
por: Puskarich, M, et al.
Publicado: (2009)

Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring
por: De Block, C, et al.
Publicado: (2005)

OR26-4 Glucocorticoid Receptor Expression and Signaling During Critical Illness, in Relation to the Duration of Illness and the Systemic Glucocorticoid Availability: A Prospective, Observational, Cross-Sectional Human and a Translational Mouse Study
por: Téblick, Arno, et al.
Publicado: (2022)

OR17-1 Changes in the Hypothalamic-Pituitary-Adrenal Axis during Pediatric Critical Illness
por: Jacobs, An, et al.
Publicado: (2019)

Withholding parenteral nutrition during the first week of critical illness increases plasma bilirubin but lowers the incidence of cholestasis and gallbladder sludge
por: Vanwijngaerden, YM, et al.
Publicado: (2013)

Insufficient activation of autophagy allows accumulation of cellular damage and may contribute to sustained organ failure in prolonged critically ill patients
por: Gunst, J, et al.
Publicado: (2011)

Variability of insulin sensitivity during the first 4 days of critical illness
por: Pretty, C, et al.
Publicado: (2012)

Relation of Resting Membrane Polarization and Insulin Resistance in Critically Ill Patients
por: Koch, S, et al.
Publicado: (2015)

Which variables affect strict glycaemic control with intensive insulin therapy in postoperative/post-traumatic critically ill patients?
por: Weiss, M, et al.
Publicado: (2009)

Tight glucose control by intensive insulin therapy in Belgian ICU: an evaluation of practice
por: Preiser, JC, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1s1afhp14lnlnq90qmjevqikh9